LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,291,142
تعداد دریافت فایل اصل مقاله7,266,809
Raza, Fathima, Vaidyanathan, Anand, Vijayaragavalu, Sivakumar. (1401). Bone Morphogenetic Protein as Bone Additive around Dental Implant and its Impact on Osseointegration: a Systematic Review. سامانه مدیریت نشریات علمی, 23(Supplement-September-2022), 336-348. doi: 10.30476/dentjods.2021.90931.1536
Fathima Banu Raza; Anand Kumar Vaidyanathan; Sivakumar Vijayaragavalu. "Bone Morphogenetic Protein as Bone Additive around Dental Implant and its Impact on Osseointegration: a Systematic Review". سامانه مدیریت نشریات علمی, 23, Supplement-September-2022, 1401, 336-348. doi: 10.30476/dentjods.2021.90931.1536
Raza, Fathima, Vaidyanathan, Anand, Vijayaragavalu, Sivakumar. (1401). 'Bone Morphogenetic Protein as Bone Additive around Dental Implant and its Impact on Osseointegration: a Systematic Review', سامانه مدیریت نشریات علمی, 23(Supplement-September-2022), pp. 336-348. doi: 10.30476/dentjods.2021.90931.1536
Raza, Fathima, Vaidyanathan, Anand, Vijayaragavalu, Sivakumar. Bone Morphogenetic Protein as Bone Additive around Dental Implant and its Impact on Osseointegration: a Systematic Review. سامانه مدیریت نشریات علمی, 1401; 23(Supplement-September-2022): 336-348. doi: 10.30476/dentjods.2021.90931.1536

Bone Morphogenetic Protein as Bone Additive around Dental Implant and its Impact on Osseointegration: a Systematic Review

Journal of Dentistry
مقاله 1، دوره 23، Supplement-September-2022، آذر 2022، صفحه 336-348    اصل مقاله (439.19 K)
نوع مقاله: Systematic Review
شناسه دیجیتال (DOI): 10.30476/dentjods.2021.90931.1536
نویسندگان
Fathima Banu Raza1؛ Anand Kumar Vaidyanathan* 2؛ Sivakumar Vijayaragavalu3
1Dept. of Prosthodontics, Faculty of Dental Sciences, Sri Ramachandra Institute of Higher Education and Research (SRIHER; Deemed to be University [DU]), Porur, Chennai 600 116, Tamil Nadu, India.
2Dept. of Life Sciences(Zoology) Manipur University, Imphal 795003, Manipur, India.
3Dept. of Prosthodontics, Faculty of Dental Sciences, Sri Ramachandra Institute of Higher Education and Research (SRIHER; Deemed to be University [DU]), Porur, Chennai 600 116, Tamil Nadu, India
چکیده
Statement of the Problem: Bone morphogenetic protein (BMP), a potential osteoinductive agent, was systematically reviewed for merits and demerits when used as a bone additive that was intervened during the surgical phase of dental implant placement; and suitable drug carriers that could withstand the functional load and deliver BMP at its lowest concentration.
Purpose: To identify the carriers and concentration of BMP acceptable during surgical phase of implant placement and evaluate its efficacy in bone gain and osseointegration.
Materials and Method: The study design was systematic review. Literature search as per PICO format was carried out within a time range from 2000 to July 2021. The review followed PRISMA guidelines and registered with the PROSPERO (CRD42020171667). The focus question included the population with an intra-oral implant placed in both animal and human models that were intervened with BMP-2 as an external additive biomaterial during the surgical phase. 2631 articles selected from the initial search were systematically filtered and yielded 16 articles that were qualitatively analysed.
Results: The inter-rater reliability and level of agreement were 93.71%, κ(Kappa)>0.81 respectively. Results revealed the collagen carrier was commonly used for BMP delivery but lacked the property to withstand functional load and sustained release. BMP concentration varied in the range of 0.215µg to 0.8mg and the study revealed significantly indifferent outcome with low dose compared to the highest dose. BMP supplement showed better osseointegration in comparison with non-supplemented sites during the early period (within 6 months).
Conclusion: BMP at lower concentrations and with appropriate carriers, collagen sponge, hydroxyapatite/tricalcium phosphate (HA/TCP) with a bio ceramic bulking agent, and poly (D, L-lactide-co-glycolic acid) (PLGA)  reinforced with gelatin/HA/TCP accelerated bone growth during the initial stages of healing. Further long-term clinical trials for dental implant, analysing the sustained release of BMP with biodegradable and load-bearing carriers should be considered.
کلیدواژه‌ها
Bone Morphogenetic Protein 2؛ Drug carrier؛ Bone-Implant interface
سایر فایل های مرتبط با مقاله
مراجع
  • Queiroz TP, Souza FÁ, Okamoto R, Margonar R, Pereir-a-Filho VA, Garcia IR, et al. Evaluation of Immediate Bone-Cell Viability and of Drill Wear After Implant Osteotomies: Immunohistochemistry and Scanning Electron Microscopy Analysis. J Oral Maxillofac Surg. 2008; 66: 1233-1240.
  • Hadjidakis DJ, Androulakis II. Bone Remodeling. Ann N Y Acad Sci. 2006; 1092: 385–396.
  • Insua A, Monje A, Wang HL, Miron RJ. Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss. J Biomed Mater Res Part A. 2017; 105: 2075–2089.
  • Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018; 18: e8.
  • Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747–754.
  • Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury. 2005; 36: S20–S27.
  • Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000: 10–27.
  • Pryor LS, Gage E, Langevin CJ, Herrera F, Breithaupt AD, Gordon CR, et al. Review of Bone Substitutes. Craniomaxillofac Trauma Reconstr. 2009; 2: 151–160.
  • Schlickewei W, Schlickewei C. The Use of Bone Substitutes in the Treatment of Bone Defects- the Clinical View and History. Macromol Symp. 2007; 253: 10–23.
  • Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med. 2011; 9: 66.
  • Lienemann PS, Lutolf MP, Ehrbar M. Biomimetic hydrogels for controlled biomolecule delivery to augment bone regeneration. Adv Drug Deliv Rev. 2012; 64: 1078-1089.
  • Gibney K. Bone augmentation in oral implantology. Br Dent J. 2007; 203: 112–112.
  • Urist MR, Strates BS. Bone Morphogenetic Protein. J Dent Res. 1971; 50: 1392–1406.
  • Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242: 1528-1534.
  • Kim SY, Lee Y, Seo SJ, Lim JH, Kim YG. Effects of escherichia coliderived recombinant human bone morphogenetic protein-2 loaded porous hydroxyaptite-based ceramics on calvarial defect in rabbits. J Bone Metab 2017; 24: 23.
  • Hua W, Yankui L, Anmin C, Zhiling Q, Jige C. Extraction, purification and identification of bone morphogenetic protein in conditioned medium of osteosarcoma cell (MG -63). Chinese-German J Clin Oncol. 2003; 2: 234–236.
  • Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000; 57: 2207–2214.
  • Benglis D, Wang MY, Levi AD. A Comprehensive Review of the Safety Profile of Bone Morphogenetic Protein in Spine Surgery. Oper Neurosurg. 2008; 62: ONS423–ONS231.
  • Cheung A, Phillips AM. Bone morphogenetic proteins in orthopaedic surgery. Curr Orthop. 2006; 20: 424–429.
  • Misch CM. Bone augmentation of the atrophic posterior mandible for dental implants using rhBMP-2 and titanium mesh: clinical technique and early results. Int J Periodontics Restorative Dent. 2011; 31: 581–589.
  • Yoo D, Tovar N, Jimbo R, Marin C, Anchieta RB, Machado LS, et al. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: An in vivo J Biomed Mater Res (Part A). 2014; 102: 1921–1927.
  • Jung RE, Glauser R, Scharer P, Hammerle CHF, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. A randomized, controlled clinical and histomorphometric study. Clin Oral Implants Res. 2003; 14: 556–568.
  • Sheikh Z, Javaid MA, Hamdan N, Hashmi R. Bone regeneration using bone morphogenetic proteins and various biomaterial carriers. Materials (Basel).2015;8:1778-1816.
  • Agrawal V, Sinha M. A review on carrier systems for bone morphogenetic protein-2. J Biomed Mater Res Part B Appl Biomater. 2017; 105: 904–925.
  • Lu SX, Fiorini T, Lee J, Prasad HS, Buxton AN, Bisch FC, et al. Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2. J Clin Periodontol. 2013; 40: 688–697.
  • Lee J, Decker JF, Polimeni G, Cortella CA, Rohrer MD, Wozney JM, et al. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical size supraalveolar peri-implant defect study in dogs. J Clin Periodontol. 2010; 37: 582–590.
  • Cottam JR, Jensen OT, Beatty L, Ringeman J. Closure of 1.5cm alveolar oral antral fistula with intra-alveolar sinus membrane elevation and bone morphogenetic protein-2/ collagen graft followed by dental implant restoration: Case report. Int J Oral Maxillofac Implants. 2013; 28: e277–e282.
  • Huh JB, Park CK, Kim SE, Shim KM, Choi KH, Kim SJ, et al. Alveolar ridge augmentation using anodized implants coated with Escherichia coli–derived recombinant human bone morphogenetic protein 2. Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 2011; 112: 42–49.
  • Fiorellini JP, Buser D, Riley E, Howell TH. Effect on bone healing of bone morphogenetic protein placed in combination with endosseous implants: a pilot study in beagle dogs. Int J Periodontics Restorative Dent. 2001; 21: 41–47.
  • Matin K, Senpuku H, Hanada N. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats Khairul Matin, Hidenobu Senpuku, Nobuhiro Hanada, Hidehiro Ozawa, Sadakazu Ejiri. Int J Oral Maxillofac Implants. 2003; 18: 211-217.
  • Lyu HZ, Lee JH. The efficacy of rhBMP-2 loaded hydrogel composite on bone formation around dental implants in mandible bone defects of minipigs. Biomater Res. 2020; 24: 1–7.
  • Schorn L, Sproll C, Ommerborn M, Naujoks C, Kübler NR, Depprich R. Vertical bone regeneration using rhBM-P-2 and VEGF. Head Face Med. 2017; 13: 1–11.
  • Tan MH, Chanchareonsook N, Jansen JA, Yu N, Liu EWY, Goh BT. The use of biphasic calcium phosphate with or without bone morphogenic protein-2 for bone regeneration during immediate implant placement in a micropig model: A pilot study. J Oral Maxillofac Surg Med Pathol. 2020; 32: 19–25.
  • Chao YL, Wang TM, Chang HH, Lin LD. Effects of low-dose rhBMP-2 on peri-implant ridge augmentation in a canine model. J Clin Periodontol. 2021; 48: 734–744.
  • Chao YL, Lin LD, Chang HH, Wang TM. Preliminary evaluation of BMP-2-derived peptide in repairing a peri-implant critical size defect: a canine model. J Formos Med Assoc. 2021; 120: 1212–1220.
  • Sun YK, Cha JK, Thoma DS, Yoon SR, Lee JS, Choi SH, et al. Bone regeneration of peri-implant defects using a collagen membrane as a carrier for recombinant human bone morphogenetic protein-2. Biomed Res Int. 2018; 2018: 1–9.
  • Chang HC, Yang C, Feng F, Lin FH, Wang CH, Chang PC. Bone morphogenetic protein-2 loaded poly (D,L-lactide-coglycolide) microspheres enhance osteogenic potential of gelatin/hydroxyapatite/β-tricalcium phosphate cryogel composite for alveolar ridge augmentation. J Formos Med Assoc. 2017; 116: 973–981.
  • Smeets R, Maciejewski O, Gerressen M, Spiekermann H, Hanisch O, Riediger D, et al. Impact of rhBMP-2 on regeneration of buccal alveolar defects during the osseointegration of transgingival inserted implants. Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology 2009; 108: e3–e12.
  • Jung RE, Windisch SI, Eggenschwiler AM, Thoma DS, Weber FE, Hämmerle CHF. A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin Oral Implants Res. 2009; 20: 660–666.
  • Ragheb NA, Rekaby A, Farahat A. Bone morphogenetic protein effect on implant stability and bone height in immediately loaded implant supported mandibular overdenture (randomized clinical trial). Int Dent Med J Adv Res. 2017; 3: 1–7.
  • Mayfield L, Nobréus N, Attström R, Linde A. Guided bone regeneration in dental implant treatment using a bioabsorbable membrane. Clin Oral Implants Re.s 1997; 8: 10–17.
  • Zitzmann NU, Naef R, Schärer P. Resorbable versus nonresorbable membranes in combination with Bio-Oss for guided bone regeneration. Int J Oral Maxillofac Implants. 1998; 12: 844–852.
  • Wong ML, Griffiths LG. Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization. Acta Biomater. 2014; 10: 1806–1816.
  • Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, et al. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent. 1996; 16: 524–537.
  • Hunt DR, Jovanovic SA, Wikesjö UME, Wozney JM, Bernard GW. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A Pilot Study. J Periodontol. 2001; 72: 651–658.
  • Nevins M, Kirker-Head C, Nevins M, Wozney JA, Palmer R GD. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int J Periodontics Restor Dent. 1996; 16: 8–19.
  • Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 2007; 59: 339–359.
  • Geiger M. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev. 2003; 55: 1613–1629.
  • Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UME. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations. Clin Oral Implants Res. 2008; 19: 1027–1033.
  • Wikesjö UME, Qahash M, Polimeni G, Susin C, Shanaman RH, Rohrer MD, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol. 2008; 35: 1001–1010.
  • Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang X, Soo C, et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng. 2007; 13: 501–512.
  • Xia Y, Xu Q, Wang C, Pack DW. Protein encapsulation in and release from monodisperse double-wall polymer microspheres. J Pharm Sci. 2013; 102: 1601–1609.
  • Xie J, Ng WJ, Lee LY, Wang CH. Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray. J Colloid Interface Sci. 2008; 317: 469–476.
  • Liu Y, Degroot K, Hunziker E. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone. 2005; 36: 745-757.
آمار
تعداد مشاهده مقاله: 1,078
تعداد دریافت فایل اصل مقاله: 633


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب